European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

STADA Arzneimittel AG, Bad Vilbel, Germany

Innovation Champion DE Commercial # 100
Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

STADA Arzneimittel AG

Identification

Ut
District Court of Frankfurt HRB 71290
Sirul
Siren 891170003
Siret
Siret 89117000300018
Lei
529900FMTTLMH0P0DL10
EUID
DEM1201.HRB71290

Address

Stadastr. 2 - 18, 61118 Bad Vilbel, Germany

Corporate purpose

71.12
Engineering activities and related technical consultancy

(a) The development, testing, manufacture, approval, application, acquisition and sale, import and export, as well as the supply, distribution, (co-distribution) of and trade in products of all kinds (including related raw materials such as active pharmaceutical ingredients and semi-finished products) for the global healthcare market, in particular in the pharmaceutical, biotechnical, chemical and cosmetic industries, medical and laboratory technology, hospital supplies, medical devices as well as the dietetic food and confectionery industry (incl … Show more

Financials

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Persons

Marketing & Tech

Network

Loading network

DATA SERVICES

Unlock the full potential of processed company data with our API or Quarterly Exports.

Publications

Year 2025 in Euipotm
92 trademark filings (83 wordmarks, 9 word figurative marks): ACIZOR, AFIVEG, ALIUD, AZEFLONE, Aferovio, Axurenave, BETRYX, BILASTAD, Bedufora, Biprocril, Bisomex, CARBOFEO, Cardovia, DITEL, DOLO …
16 Dec 2025
No longer Authorized signatory (ppa): Christoph Dengler
Year 2025 in Dpmam
3 wordmarks: ACCURAT, Angistad , CYCLO - cell, Dignodolin, ELO HYDRATED, ELO PRO, ELO PUR, Kräutersegen, LYMPHIMED, Locatonsil, Metoplus F STADA, Metoproloc, OPTICROM, ORGATRACT, Omnivit …
20 Oct 2025
List of board members
13 Oct 2025
No longer Authorized signatory (ppa) (2)
29 Sept 2025
Aufsichtsrat
22 Sept 2025
Original document: “Liste der Aufsichtsratsmitglieder zum 22.09.2025“
25 Aug 2025
Authorized signatory (ppa): Ruben Lopez Bouza · No longer Authorized signatory (ppa): Cigdem Erek
21 Aug 2025 via Nidda Healthcare GmbH
Shareholder: Nidda Healthcare GmbH
11 Aug 2025 via Nidda German Topco GmbH also 03/02/2025, 01/02/2024, 30/01/2023, 30/01/2023, 17/01/2022, 17/01/2022, 17/12/2020, 17/12/2020, 02/01/2020, 02/01/2020, 08/02/2019, 08/02/2019
Shareholder: Nidda German Topco GmbH
9 Aug 2025 as STADA Arzneimittel
Phone Number · Website
17 Jul 2025
Authorized signatory (ppa): Cigdem Erek · No longer Authorized signatory (ppa): Holger Buschmann
17 Jun 2025
Aufsichtsrat
16 Jun 2025
No longer Authorized signatory (ppa): Stephan Eder
16 Jun 2025
List of board members
4 Jun 2025
Patent: Method of Producing a Recombinant Protein in a Host Cell Which HAS a Disabled Rhamnose Metabolism AS Well AS Expression Vectors, Host Cells and Recombinant Proteins Thereof
2 Apr 2025
Patent: Water-Soluble Granular Material for Producing a Drinking Solution
26 Mar 2025
Company statute · (a) The development, testing, manufacture, approval, application, acquisition and sale, import and export, as well as the supply, distribution, (co-distribution) of and trade in …
12 Mar 2025
Patent: Method for Producing an Apixaban Granulate
26 Feb 2025
Original document: “Gesellschaftsvertrag / Satzung / Statut“
4 Feb 2025
Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023 · Earnings statement for 31/12/2023 · Shareholdings (104 companies)
21 Jan 2025
Consolidated Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023 · Earnings statement for 31/12/2023 · Shareholdings (107 companies)
Year 2024 in Euipotm
93 wordmarks: !$tada, AMPINOR, AMUCLUST, Adixemin, Axylamex, Axylamo, BILLARTIN, BISOPROFEN, BLADUZOL, Biprocril, Bisoclear, Bladasin, Blexafy, Blocoril, Bugvi …
4 Oct 2024
Wordmark: “LADIVAL“
6 Aug 2024
Wordmark: “OPTICROM“
6 Aug 2024
Wordmark: “Omnivit“
31 Jul 2024
List of board members
Year 2024 in Euipods
14 registered designs
20 Jun 2024
Original document: “Liste der Aufsichtsratsmitglieder zum 20.06.2024“
19 Jun 2024
Patent: Atorvastatin Composition
7 Jun 2024
Aufsichtsrat
22 Apr 2024
Authorized signatory (ppa): Georgios Kordelas, Alexandra Panusch · No longer Authorized signatory (ppa): Julia Schüssler
6 Mar 2024
Authorized signatory (ppa): Daniel Buschmann · No longer Authorized signatory (ppa): Volker Sydow
14 Feb 2024
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022 · Shareholdings (76 companies)
10 Jan 2024
Consolidated Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022 · Shareholdings (115 companies)
Year 2023 in Euipotm
61 trademark filings (53 wordmarks, 8 word figurative marks): AFVISBRI, APOLO+, ARTERIUM, Abutrax, Bulbotrax, CardioM, DOLOSPED, DUOFILM Cryo, Degacid, ELOTRANS, ELOTRANS reload, FILGRA, FLADREN …
Year 2023 in Epobase
4 European patent filings: Method for Producing a Stabilized Diamine Oxidase Lyophilisate and Pharmaceutical Dosage Form …
Year 2023 in Dpmam
6 wordmarks: All you need is gesund, FEMI AL, FEMIN AL, IMMUNOSTAD …
27 Nov 2023
Authorized signatory (ppa): Wolfgang Rauch · No longer Authorized signatory (ppa) (1)
21 Nov 2023
Aufsichtsrat
11 Oct 2023
Authorized signatory (ppa): Nikola Veizovic
16 Aug 2023
List of board members
10 Aug 2023
Original document: “Liste der Aufsichtsratsmitglieder zum 10.08.2023“
26 Jul 2023
Authorized signatory (ppa): Christoph Martin
13 Apr 2023
Member of the Executive Board: M. Pagan Fernandez · Authorized signatory (ppa) (4) · No longer Authorized signatory (ppa) (3)
23 Feb 2023
Annual report
23 Feb 2023
Consolidated Annual report for the year ending 31/12/2022
19 Jan 2023
Member of the Executive Board: Boris Döbler · Authorized signatory (ppa): Adriana Reimer · No longer Authorized signatory (ppa): Boris Döbler
Year 2022 in Euipotm
83 trademark filings (79 wordmarks, 3 word figurative marks, 1 other mark): AVITA, AZIBA, BCONIZ, BRASTIB, BoneNanza, COTYLENA, Cannab-i-gnosis, DIOSMIN STADA, DIOSTAD, DUOGON, DUOGRIP, DUOGYLIN …
Year 2022 in Dpmam
10 trademark filings (3 wordmarks, 2 figurative marks, 2 word figurative marks): Dignodolin, OPTICROM, Omnivit, TADAFEEL, VenoSupport STADA …
Year 2022 in Epobase
5 European patent filings: Process for the Preparation of a Bortezomib Ester Solution …
27 Sept 2022
Annual report for the year ending 31/12/2021
26 Sept 2022
Authorized signatory (ppa): Gisela Müller-Nagel · No longer Member of the Executive Board: Wolfgang Ollig
22 Sept 2022
Utility patent: Gebrauchsfertige Bortezomib-Lösung
Year 2022 in Euipods
51 registered designs
25 Aug 2022
Annual report
18 Aug 2022
Authorized signatory (ppa): Christine S. Abel
17 Aug 2022
Annual report
15 Aug 2022
Utility patent: Ready-to-use Bortezomib Solution
15 Aug 2022
Utility patent: Gebrauchsfertige Bortezomib-Lösung
14 Jul 2022
Utility patent: Gebrauchsfertige Bortezomib-Lösung
6 Jul 2022
No longer Authorized signatory (ppa) (1)
31 May 2022
Authorized signatory (ppa): Stephan Eder
10 May 2022
Consolidated Annual report for the year ending 31/12/2021
13 Apr 2022
Authorized signatory (ppa): Holger Buschmann
12 Apr 2022
Annual report for the year ending 31/12/2021
1 Apr 2022
Authorized signatory (ppa): Holger Buschmann · No longer Authorized signatory (ppa) (1)
16 Mar 2022
Authorized signatory (ppa): Dirk Holtkamp
14 Mar 2022
Annual report
8 Mar 2022
Authorized signatory (ppa): Dirk Holtkamp
27 Jan 2022
No longer Authorized signatory (ppa) (1)
Year 2021 in Euipotm
64 trademark filings (57 wordmarks, 7 word figurative marks): AURASIN, AXIPIO, Artrium, Atrium, BITAXAR, Bamixol, CETEBE, DASATINOR, DASATINY, DuofilmStylo, EVERYCARE, Esaril, EveryCare by STADA …
30 Nov 2021
Enterprise Administration
30 Nov 2021
Exploitation of proprietary medicinal products
30 Nov 2021
Exploitation of medicines and other health products
24 Nov 2021
Original document: “Liste der Aufsichtsratsmitglieder zum 24.11.2021“
Year 2021 in Dpmam
35 trademark filings (21 wordmarks, 1 figurative mark, 8 word figurative marks): A-Z Multi Vit AL, B12 Trink Vit AL, Bronchiplantal, Bronchobonial, D3+K2 DuoProtect Vit AL, Dolordonial, EVERYCARE …
19 Oct 2021
Authorized signatory (ppa): Jessica Schönborn
22 Sept 2021
Company statute · (a) the development, testing, manufacture, approval, promotion, acquisition and sale, import and export, distribution and trade of products of all kinds (including related raw …
26 Aug 2021
Annual report
Year 2021 in Euipods
70 registered designs
19 Aug 2021
Annual report for the year ending 31/12/2020
19 Aug 2021
Original document: “Gesellschaftsvertrag / Satzung / Statut“
18 Aug 2021
Annual report
3 Aug 2021
Authorized signatory (ppa): Benjamin Fischer, Bryan Chu Young Kim
8 Jul 2021
Authorized signatory (ppa): Tobias Günthör · No longer Authorized signatory (ppa) (2)
15 Jun 2021
Annual report for the year ending 31/12/2020
10 Jun 2021
Consolidated Annual report for the year ending 31/12/2020
28 May 2021
No longer Authorized signatory (ppa) (1)
11 May 2021
Member of the Executive Board: Wolfgang Ollig
14 Apr 2021
Member of the Executive Board: Simone Berger · No longer Authorized signatory (ppa) (2) · Authorized signatory (ppa) (1)
9 Mar 2021
Authorized signatory (ppa) (1)
3 Mar 2021
Annual report
23 Feb 2021
Patent: Pharmazeutische Pemetrexed-Lösung
21 Feb 2021
Patent: USE of a Pemetrexed Concentrate Solution
12 Feb 2021
Authorized signatory (ppa): Volker Sydow
25 Jan 2021
Member of the Executive Board: Peter Goldschmidt, Wolfgang Ollig, M. Pagan Fernandez · Authorized signatory (ppa): Ingo Buschhüter, Julia Schüssler · No longer Authorized signatory (ppa) (3)
28 Dec 2020
Company statute
Year 2020 in Dpmam
11 trademark filings (1 wordmark, 4 figurative marks, 2 other marks): AYUNOVA, METIPHEN AL, METOPROLOL ZT STADA, Omnivit, ZOK …
Year 2020 in Euipods
23 registered designs
8 Dec 2020
Original document: “Gesellschaftsvertrag / Satzung / Statut“
19 Nov 2020
Authorized signatory (ppa): Yann Brun · No longer Authorized signatory (ppa) (1)
Year 2020 in Euipotm
33 trademark filings (30 wordmarks, 2 word figurative marks, 1 other mark): ADZIMLAR, BEVIMLAR, BEVZIMLA, CANNABISTADA, CANNASTADA, CANNISTADA, CENVYSIO, CENVYSO, CIZMILAR, CLOXOL, DuoVit, FORDIAB …
6 Nov 2020
The Annual General Meeting on 24.09.2020 approved the transfer of the shares of the remaining shareholders to the main …
9 Oct 2020
Patent: Method of Producing a Recombinant Protein in a Host Cell Which HAS a Disabled Rhamnose Metabolism AS Well AS Expression Vectors, Host Cells and Recombinant Proteins Thereof
2 Sept 2020
No longer Authorized signatory (ppa): Stephan Eder
26 Aug 2020
Annual report
11 Aug 2020
Authorized signatory (ppa): Stephan Eder
10 Aug 2020
Annual report
Year 2020 in Dpmap
7 patent filings (2 utility patent): Lichtschutzzubereitung mit Mikropigmenten …
12 Jun 2020 via eG Labo - Laboratoires Eurogeneric SAS also 22/02/2018
President: eG Labo - Laboratoires Eurogeneric SAS
12 Jun 2020 via eG Labo - Laboratoires Eurogeneric SAS
Chair of the Supervisory Board: eG Labo - Laboratoires Eurogeneric SAS
10 Jun 2020
Authorized signatory (ppa): Ruben Lopez Bouza, Rehan Smit · No longer Authorized signatory (ppa) (2)
27 May 2020
Patent: Use of Antioxidants for the Preparation of Pharmaceutical or Cosmetic Compositions for Protecting the Skin From Damages by Infrared-Radiations
27 May 2020
Patent: Use of Antioxidants for the Preparation of Pharmaceutical or Cosmetic Compositions for Protecting the Skin From Damages by Infrared-Radiations
25 May 2020
Annual report for the year ending 31/12/2019
15 Apr 2020
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019 · Shareholdings (98 companies)
24 Mar 2020
Consolidated Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019 · Shareholdings (100 companies)
10 Mar 2020
Annual report
9 Mar 2020
Utility patent: Ready-to-use Bortezomib Solution
9 Mar 2020
Utility patent: Ready-to-use Bortezomibester solution
17 Feb 2020
Member of the Executive Board: Wolfgang Ollig · No longer Member of the Executive Board: Mark Keatley
17 Feb 2020
Authorized signatory (ppa) (1)
14 Jan 2020
Authorized signatory (ppa) (1)
1 Jan 2020 in France
Address · Legal form · Name: STADA ARZNEIMITTEL AG · Segment clas­si­fi­ca­tion
9 Dec 2019
No longer Authorized signatory (ppa) (2) · Authorized signatory (ppa) (1)
29 Nov 2019
Authorized signatory (ppa): Boris Döbler · No longer Authorized signatory (ppa) (1)
Year 2019 in Dpmam
38 trademark filings (5 wordmarks, 4 word figurative marks, 1 other mark): AMOXI STADA, Bronchostop, Carilaxan, FUNGAREST, GASTRIUM, GASTROCUR, GASTROSAN, IP-Vac, IP-Vax, Multilind DermaCare …
Year 2019 in Euipotm
20 trademark filings (10 wordmarks, 1 figurative mark, 9 word figurative marks): BIMCIZA, DuoProtect, ELDISINE, Hoggar, Multilind DermaProtect, RAMIRA, REDUCOLD, XYLOSOFT, cell-immun, РАМИРА …
29 Oct 2019
Patent: Lichtschutzzubereitungen umfassend feste Lipidnanopartikel
Year 2019 in Euipods
22 registered designs
26 Sept 2019
Authorized signatory (ppa) (1)
27 Jun 2019
List of board members
4 Jun 2019
Patent: Lichtschutzzubereitung mit Mikropigmenten
27 May 2019
No longer Authorized signatory (ppa) (1)
20 May 2019
Annual report for the year ending 31/12/2018
12 Apr 2019
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018 · Earnings statement for 31/12/2018 · Change of shareholdings (98 companies)
2 Apr 2019
Authorized signatory (ppa) (1)
2 Apr 2019
Consolidated Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018 · Earnings statement for 31/12/2018 · Shareholdings (101 companies)
27 Mar 2019
Patent: Pharmaceutical Pemetrexed Solution
13 Mar 2019
Authorized signatory (ppa) (4) · No longer Authorized signatory (ppa) (3)
5 Mar 2019
Authorized signatory (ppa) (2)
20 Feb 2019
Patent: Powdery Mixture for Producing Tablets Containing Levetiracetam
25 Jan 2019
No longer Authorized signatory (ppa) (2) · Authorized signatory (ppa) (2)
4 Jan 2019
Patent: Verfahren zur Herstellung von Lichtschutzzubereitungen, umfassend organische UV-Filter in fester, feinverteilter Form
Year 2018 in Dpmam
125 trademark filings (3 wordmarks, 3 word figurative marks): ALIUD PHARMA - ALTERNATIVEN SCHAFFEN, ALIUD PHARMA - GEMEINSAM.KOMPETENT.GESUND, Beautyslim, Bioslim, Bronchocur, Curabiotikum, Curagast …
Year 2018 in Euipotm
34 trademark filings (30 wordmarks, 4 word figurative marks): ABLYMICO , AVEQUAY , BEVLATRU , BEVTONO, BIMAVA , DORMIRAPID, DUOPROTECT D3+K2 STADA, DUOPROTECT STADA, DUOPROTEKT D3+K2 STADA …
2 Nov 2018
Authorized signatory (ppa) (1)
Year 2018 in Dpmap
6 patent filings: Verpresste feste pharmazeutische Zusammensetzung, umfassend amorphes partikuläres Valsartan als Wirkstoff …
15 Oct 2018
Company statute
15 Oct 2018
Company statute
17 Sept 2018
Member of the Executive Board: Peter Goldschmidt · No longer CEO: Claudio Albrecht
29 Aug 2018
Patent: Composition Comprising Anti-Gluten Antibodies and Tannins
24 Jul 2018
Original document: “Gesellschaftsvertrag / Satzung / Statut“
23 Jul 2018
Company statute · (a) the development, testing, manufacture, approval, promotion, import and export, and distribution and distribution of all kinds of products (including related raw materials and …
17 Jul 2018
Original document: “Gesellschaftsvertrag / Satzung / Statut“
9 Jul 2018
Member of the Executive Board: M. Pagan Fernandez
9 Jul 2018
Authorized signatory (ppa) (4)
19 Jun 2018
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017
22 May 2018
No longer Member of the Executive Board: Barthold Piening
Year 2018 in Euipods
11 registered designs
2 May 2018
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017 · Shareholdings (69 companies)
2 May 2018
Patent: Orodispersible Tablet Containing an H1 Antihistamine
20 Mar 2018
Control: Nidda Healthcare GmbH · Control: Nidda Healthcare GmbH
19 Mar 2018
Consolidated Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017 · Change of shareholdings (100 companies)
27 Feb 2018
No longer Authorized signatory (ppa) (1)
19 Dec 2017
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
Year 2017 in Epobase
5 European patent filings: Solid Oral Pharmaceutical Dosage Form with Extended Active Principle Release Comprising Mirabegron …
Year 2017 in Dpmam
26 trademark filings (3 wordmarks, 1 word figurative mark): DuoProtect, FRUBIASE, LADIVAL, LADIVAL Für sonnengesunde Haut, Ladival Alpin, Ladival protect, MOMERHINIT AL, MOMETARHINIT AL, REDOX …
7 Nov 2017
No longer Authorized signatory (ppa) (3)
20 Oct 2017
CEO: Claudio Albrecht · Member of the Executive Board: Mark Keatley · No longer Member of the Executive Board: Bernhard Düttmann, E. C. Tjeenk Willink
20 Sept 2017
Annual report for the year ending 31/12/2016
Year 2017 in Euipotm
21 trademark filings (20 wordmarks, 1 word figurative mark): Arterioflow, Arteriofree, Arteroflow, Arterofree, BYLTISSA, DOPACAPONE, EFATRIPLEG, GRIPPOPROTECT, GRIPPROTECT, Lactobiotic, MULTISEPTIC …
1 Aug 2017
Member of the Executive Board: Bernhard Düttmann, E. C. Tjeenk Willink · No longer Member of the Executive Board: Helmut Kraft, Matthias Wiedenfels
17 Jul 2017
Authorized signatory (ppa) (1)
30 Jun 2017 via STADA GmbH
Merger, No longer Control, No longer Control: STADA GmbH
27 Apr 2017
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016 · Shareholdings (72 companies)
25 Apr 2017
Consolidated Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016 · Change of shareholdings (107 companies)
6 Apr 2017
Member of the Executive Board: Barthold Piening
13 Feb 2017
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
26 Jan 2017
Patent: Ready-to-use Bortezomib Solution
26 Jan 2017
Patent: Process for preparing a bortezomibester solution
Year 2016 in Euipotm
34 trademark filings (27 wordmarks, 1 figurative mark, 6 word figurative marks): ALIUD, BUCCOSTAD, CAVOLEY, DOLORSTAD, DURPEGA, EQLAVIO, ETRAGA, FRUCTOSOLV, Histasolv, KEYLAZA, LACTOSTAD, LADIVAL …
16 Dec 2016
Authorized signatory (ppa) (1)
Year 2016 in Epobase
8 European patent filings: Solid Pharmaceutical Oral Dosage Form Comprising an Extended Release of the Active Ingredient Comprising Mirabegron …
Year 2016 in Dpmam
64 trademark filings (32 wordmarks, 2 figurative marks, 4 word figurative marks): AESCULAVIT, AMINOX, AMINOX STADA, Atoderm, Atolind, Atopilind, CALMALIND, D2TWATER, DAOVET, DTXWATER, Dermaintens …
9 Dec 2016
Company statute
3 Nov 2016
Original document: “Gesellschaftsvertrag / Satzung / Statut“
17 Oct 2016
Original document: “Gesellschaftsvertrag / Satzung / Statut“
17 Oct 2016
Original document: “Gesellschaftsvertrag / Satzung / Statut“
17 Oct 2016
Original document: “Gesellschaftsvertrag / Satzung / Statut“
7 Oct 2016
Annual report for the year ending 31/12/2015
6 Oct 2016
No longer Authorized signatory (ppa) (4)
26 Sept 2016
No longer Member of the Executive Board: Hartmut Retzlaff
8 Jul 2016
No longer Authorized signatory (ppa) (1)
30 Jun 2016
Consolidated Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015 · Shareholdings (105 companies)
22 Jun 2016
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
21 Jun 2016
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015 · Change of shareholdings (106 companies)
Year 2015 in Euipotm
40 trademark filings (34 wordmarks, 1 figurative mark, 5 word figurative marks): BONSTYMA, CETEGRIPPAL, COSMOCEUTICALS, DORMISTAD, Dabopar, Easofen, FLATUCONE, FLURBIDOLOR, FLURBISTAD, IBUGRIPP …
24 Dec 2015
Utility patent: Wasserlösliches Granulat zur Herstellung einer Trinklösung
3 Dec 2015
Company statute
27 Nov 2015
No longer Authorized signatory (ppa) (1) · Capital: €162.1M · Company statute
13 Nov 2015
Utility patent: Water-soluble granules for the preparation of a drinking solution
13 Nov 2015
Utility patent: Wasserlösliches Granulat zur Herstellung einer Trinklösung
Year 2015 in Dpmam
33 wordmarks: AYUNOVA, Angiostad, Angiostas, Angistad, Angistad , Cortilind, Cortisolind, Cortistad, FILOREANE, FILORYAL, FILORYAL Detox Infusion, FILORYAL Skin Infusion, HEMODORM, HEMOLAX …
Year 2015 in Epobase
5 European patent filings: Oral Febuxostat Tablet …
30 Sept 2015
No longer Authorized signatory (ppa) (1)
20 Aug 2015
Original document: “Gesellschaftsvertrag / Satzung / Statut“
29 Jun 2015
Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014 · Change of shareholdings (104 companies)
8 Jun 2015
Authorized signatory (ppa) (1)
8 Jun 2015
Consolidated Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014 · Change of shareholdings (100 companies)
20 May 2015
By resolution of the Supervisory Board of 25.03.2015, § 5 (share capital) of the Articles of Association has been …
24 Apr 2015
Original document: “Gesellschaftsvertrag / Satzung / Statut“
30 Jan 2015
Capital: €157.6M · Company statute
26 Jan 2015
Original document: “Gesellschaftsvertrag / Satzung / Statut“
Year 2014 in Dpmam
1,102 trademark filings (28 wordmarks, 2 word figurative marks): "Thymusyl", "Uzaron", 5 FU-cell, A+B-vaccinol, ACCURAT, ACOSTAD, ACTI - cell, ACTI - kin, ACTI - stem, ACTI - thromb, ACTI - vac …
Year 2014 in Dpmap
4 patent filings (1 utility patent): Gebrauchsfertige Gemcitabin-Lösungen …
Year 2014 in Euipotm
22 trademark filings (18 wordmarks, 4 word figurative marks): CEFALSOLV, EPO-CELL PHARM, EPO-cell, EUNOVA MULTI-VITALSTOFFE, EUNOVA VET, Fructease, LAURIN Healthcare, LAURIN Medical Care, LAURIN …
18 Jul 2014
Authorized signatory (ppa): Uwe Landvatter · No longer Authorized signatory (ppa) (1) · List of board members
16 Jul 2014
Patent: Treatment of Fructose Malabsorption
11 Jul 2014
Authorized signatory (ppa) (1)
10 Jul 2014
Consolidated Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013 · Earnings statement for 31/12/2013 · Change of shareholdings (102 companies)
4 Jul 2014 via STADA GmbH
Control, Control: STADA GmbH
1 Jul 2014
List of board members
6 Jun 2014
Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013 · Earnings statement for 31/12/2013 · Change of shareholdings (107 companies)
26 Feb 2014
Capital: €157.2M · Company statute
22 Jan 2014
Original document: “Gesellschaftsvertrag / Satzung / Statut“
Year 2013 in Euipotm
4 wordmarks: FRUCTOSIN, HomeDiagnostic CheckBox, PROVOKAMIN, XASMUN
Year 2013 in Dpmap
12 patent filings: Pharmazeutische Pemetrexed-Lösung …
Year 2013 in Dpmam
6 wordmarks: Captimer, EUNOVA VET, FÜR VITAMIN C-SCHUTZ VON MORGENS BIS ABENDS. CETEBE. DAS LANGZEIT C, LACTOSTAD, LAKTOSTAD, LINARA, LINARA STADA, Mirafem AL, Moxiflox, Moxiflox STADA, STADA Vita …
9 Sept 2013
No longer Member of the Executive Board (1) · No longer Authorized signatory (ppa) (1)
13 Aug 2013
The Annual General Meeting on 05.06.2013 approved the amendment of § 6 (Authorized and conditional capital)) as well as …
5 Aug 2013
Con­vert­ible bonds
22 Jul 2013
Member of the Executive Board: Matthias Wiedenfels · No longer Authorized signatory (ppa): Matthias Wiedenfels · Authorized signatory (ppa) (3)
19 Jul 2013
Annual report for the year ending 31/12/2012
27 May 2013
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012 · Earnings statement for 31/12/2012 · Shareholdings (99 companies)
27 May 2013
Consolidated Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012 · Earnings statement for 31/12/2012 · Change of shareholdings (98 companies)
4 Mar 2013
Member of the Executive Board (1)
18 Feb 2013
Member of the Executive Board: Hartmut Retzlaff
12 Feb 2013
Capital: €154.3M · Company statute
4 Feb 2013
Capital: €154.3M · Company statute
16 Jan 2013
Patent: Process for Producing a Solid Pharmaceutical Composition Comprising the Active Ingredient Rasagiline
19 Dec 2012
Patent: Orally Administrable Composition or SET Comprising Tannin
Year 2012 in Dpmam
91 trademark filings (38 wordmarks, 10 word figurative marks): AL Aliud Pharma, AMINA, AMINA STADA, APREE, Allegra STADA, Alveola, CITROSTAR, DIE ERSTE RUNDUM-VERSORGUNG VON MORGENS BIS ABENDS …
Year 2012 in Euipotm
15 wordmarks: DAOVET, GASTRIUM, Immunostad, SILAFIL, SILAFIL STADA, SILDA, SILDA STADA, SILDAFEEL, SILDAFEEL STADA, SILDAFIL, SILDAFIL STADA, SILDENAFEEL, SILDENAFEEL STADA, SOLARVIT …
Year 2012 in Dpmap
6 patent filings: Pulverförmige Mischung zur Herstellung von Levetiracetam-Haltigen Tabletten …
29 Nov 2012
Patent: Powdered mixture for the production of Levetiracetam-containing tablets
3 Sept 2012
Company statute
25 Jul 2012
Patent: Effervescent Composition Against Cold Symptoms
24 Jul 2012
Patent: Compressed Solid Pharmaceutical Composition Comprising Amorphous Particulate Valsartan AS the Active Ingredient
8 Jun 2012
Annual report for the year ending 31/12/2011
8 May 2012
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011 · Earnings statement for 31/12/2011 · Shareholdings (105 companies)
8 May 2012
Consolidated Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011 · Earnings statement for 31/12/2011 · Change of shareholdings (103 companies)
20 Feb 2012
Capital: €153.3M · Company statute
Year 2011 in Epobase
4 European patent filings: Skin Cream for Treatment and/or Cleaning of Skin for Neurodermitis …
Year 2011 in Dpmam
133 trademark filings (58 wordmarks, 5 word figurative marks): AL.doc, AMINA, AMINA STADA, Alveola STADA, Atovacplus STADA, BENANORM, BUDEFORM, BUDEFORM STADA, BUDICOMP AL, CALMALIND, CEFPOXIM, CTRIX …
1 Dec 2011
Patent: Method for the preparation of an enriched extract FROM leaves of Vitis vinifera L
21 Nov 2011
Authorized signatory (ppa) (1)
Year 2011 in Dpmap
7 patent filings: Schmelztablette, umfassend ein Triptan oder ein atypisches Neuroleptikum …
Year 2011 in Euipotm
5 wordmarks: Aminocur, Aminostad, Axatal, LACTOSOLV, Profi-LACT
15 Sept 2011
Patent: Solid Pharmaceutical Composition, Comprehensive Donepezil Hydrochloride of Crystalline Polymorphic Form I
12 Sept 2011
Authorized signatory (ppa) (1)
22 Aug 2011
No longer Authorized signatory (ppa) (2)
1 Aug 2011
No longer Authorized signatory (ppa) (1)
5 Jul 2011
Annual report for the year ending 31/12/2010
30 May 2011 via LIFE TRANS Pharma Vertriebs GmbH
Merger: LIFE TRANS Pharma Vertriebs GmbH
30 May 2011 via STADA R & D GmbH
Merger: STADA R & D GmbH
30 May 2011
Merger: LIFE TRANS Pharma Vertriebs GmbH, STADA R & D GmbH
13 May 2011
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010 · Earnings statement for 31/12/2010 · Shareholdings (98 companies)
4 May 2011
Consolidated Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010 · Earnings statement for 31/12/2010 · Change of shareholdings (99 companies)
20 Apr 2011
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
30 Mar 2011
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
15 Feb 2011
No longer Authorized signatory (ppa) (1) · Capital: €153.1M · Company statute
7 Feb 2011
Authorized signatory (ppa) (2)
Year 2010 in Dpmam
152 trademark filings (46 wordmarks, 7 word figurative marks): Allegra STADA, Allergo-top, BELARETTE, Babette AL, Belinda AL, Bonita AL, CARBO-cure, Calcium + D STADA, Candesarplus AL, Cynthia STADA …
Year 2010 in Euipotm
11 trademark filings (10 wordmarks, 1 word figurative mark): CETRABEN, Cenoxan, Dermalog, Inkamilagro, Lactobiotik, Lactoflora, Laktobiotik, MOBIFLEX, Prixan, STADA GLUCO CARE …
13 Dec 2010
Authorized signatory (ppa) (1)
13 Dec 2010
Authorized signatory (ppa): Frank Seiler · No longer Authorized signatory (ppa) (1)
13 Dec 2010
The share capital has been conditionally increased by up to EUR 66,823,458.00 by resolution of the Annual General …
8 Nov 2010
Authorized signatory (ppa): Alice Moriz
11 Oct 2010
Authorized signatory (ppa) (1)
11 Oct 2010
Member of the Executive Board (1) · No longer Authorized signatory (ppa) (1)
Year 2010 in Dpmap
7 patent filings: Verwendung von Antioxidantien zur Herstellung einer pharmazeutischen oder kosmetischen Zusammensetzung zum Schutz der Haut gegen Schädigung durch Infrarot-Strahlung …
29 Sept 2010
Patent: Use of antioxidants to make a pharmaceutical or cosmetic composition to protect the skin against damage caused by infrared radiation
23 Aug 2010
No longer Member of the Executive Board (1)
16 Aug 2010
Authorized signatory (ppa) (1)
28 Jun 2010
Company statute
28 Jun 2010
Annual report for the year ending 31/12/2009
21 Jun 2010
List of board members
20 Apr 2010
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009 · Earnings statement for 31/12/2009 · Shareholdings (86 companies)
20 Apr 2010
Consolidated Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009 · Earnings statement for 31/12/2009 · Change of shareholdings (90 companies)
12 Apr 2010
Authorized signatory (ppa) (1)
11 Mar 2010
Patent: Treatment of fructose malabsorption
1 Mar 2010
Company statute
22 Feb 2010
Capital: €153M · Company statute
15 Feb 2010
Authorized signatory (ppa): Matthias Wiedenfels
9 Feb 2010
Patent: Composition Comprising a Hydrophobic Material and a Phospholipid
9 Feb 2010
Patent: Fixed Oral Pharmaceutical Compound Comprising a Hydrophobic Material
25 Jan 2010
Member of the Executive Board: Helmut Kraft
Year 2009 in Dpmam
73 trademark filings (26 wordmarks, 1 word figurative mark): ANASTRO-cell, APOTHEKIUM, BELARETTE, Benzbromastad, CLAIRE FISHER, CLAIRE FISHER AQUA MINERAL, CLAIRE FISHER NATUR CLASSIC, CLAIRE FISHER …
7 Dec 2009
List of board members
23 Nov 2009
Authorized signatory (ppa) (1)
Year 2009 in Euipotm
10 trademark filings (9 wordmarks, 1 word figurative mark): Auxade, FRUKTOSIN, Fepaxon, Hymaxan, LANZOSTAD, Lepaxion, STADA GLUCO RESULT, STADA GLUCO RESULT TO GO, SUMAMIGRAN …
21 Sept 2009
No longer Authorized signatory (ppa) (1)
Year 2009 in Epobase
5 European patent filings: 2-Ethoxy Benzoic Acid Derivative …
7 Sept 2009
Authorized signatory (ppa) (1)
7 Sept 2009
No longer Member of the Executive Board (1)
26 Aug 2009
Patent: Light protection preparation in the form of an O/W emulsion with a light protection factor of _> 50
26 Aug 2009
Patent: Lichtschutzzubereitung in Form einer O/W-Emulsion mit einem Lichtschutzfaktor von _> 50
26 Aug 2009
Patent: Light protection preparation in the form of a W/O emulsion with a light protection factor of _> 50
26 Aug 2009
Patent: Lichtschutzzubereitung in Form einer W/O-Emulsion mit einem Lichtschutzfaktor von _> 50
13 Jul 2009
List of board members
13 Jul 2009
Annual report for the year ending 31/12/2008
6 Jul 2009 via Mobilat Produktions GmbH also 03/07/2009
Control: Mobilat Produktions GmbH
25 May 2009
Authorized signatory (ppa) (1)
11 May 2009
Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008 · Earnings statement for 31/12/2008 · Shareholdings (78 companies)
11 May 2009
Consolidated Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008 · Earnings statement for 31/12/2008 · Shareholdings (90 companies)
19 Mar 2009
Annual report
23 Feb 2009
Capital: €152.8M · Company statute
12 Jan 2009
Authorized signatory (ppa) (1)
7 Jan 2009
Patent: Dermatics for the treatment and/or care of the skin in neurodermatites
7 Jan 2009
Patent: Dermatikum zur Behandlung und/oder Pflege der Haut bei Neurodermitits
Year 2008 in Euipotm
81 trademark filings (67 wordmarks, 6 figurative marks, 8 word figurative marks): ACCUSTAD, ALPRASEDON, Anaxira, BOLESIN, Balixum, CLADOSOL, COMBITENTS, CYTA-CELL, Cantaxel, Cellredia, Celltaxel …
15 Dec 2008
Authorized signatory (ppa) (2) · No longer Authorized signatory (ppa) (1)
Year 2008 in Dpmam
26 trademark filings (5 wordmarks, 3 word figurative marks): BICALU-cell, Curazink, Diclodolor, ELDISINE, GEMCI-cell, Gripp AL, Iritex, KETOSTAD, Lodium Stada, Lorium Stada, Mobilat, Roxi Stada …
Year 2008 in Epobase
6 European patent filings: Stabilized Statins …
29 Sept 2008
Authorized signatory (ppa) (2) · No longer Member of the Executive Board (2) · No longer Authorized signatory (ppa) (1)
18 Aug 2008
Ex officio registered: Entry of 07.08.2008 corrected in: The Authorized Capital 2005/I is cancelled
11 Aug 2008
Entry dated 30.07.2008 in column 6 b) last paragraph corrected ex officio: The Authorized Capital 2004/I is...
4 Aug 2008
List of board members
14 Jul 2008
No longer Authorized signatory (ppa) (1)
19 Jun 2008
Annual report for the year ending 31/12/2007
28 May 2008
Consolidated Annual report for the year ending 31/12/2007 · Balance sheet for 31/12/2007 · Earnings statement for 31/12/2007 · Shareholdings (90 companies)
21 May 2008
Annual report for the year ending 31/12/2007 · Balance sheet for 31/12/2007 · Earnings statement for 31/12/2007 · Shareholdings (84 companies)
27 Mar 2008
Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006 · Earnings statement for 31/12/2006 · Shareholdings (98 companies)
19 Feb 2008
Company statute
8 Feb 2008
Capital: €152.7M · Company statute
Year 2007 in Dpmam
28 wordmarks: Acylpäd, Aktilat, Aktivat, Amuretik Stada, Atenonorm Stada, Beautyslim, Bezastad, Bioslim, Bronchocur, Curabiotikum, Curagast, Curalip, Curasoft, Curavit, Curazink …
Year 2007 in Euipotm
5 wordmarks: CURACELL, Dixanor, MIRTASTAD, Prevital, Vitastad Immunisator
1 Oct 2007
Authorized signatory (ppa) (2)
26 Sept 2007
Patent: Concentrated Solution of Oxaliplatinum
26 Sept 2007
Patent: Ready to use Gemcitabine Solutions
24 Sept 2007
No longer Authorized signatory (ppa) (1)
25 Jul 2007
Annual report for the year ending 31/12/2006
Year 2007 in Dpmap
5 patent filings: Lichtschutzzubereitung mit Mikropigmenten …
18 Jun 2007
Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006 · Earnings statement for 31/12/2006 · Shareholdings (97 companies)
18 Jun 2007
Consolidated Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006 · Earnings statement for 31/12/2006 · Shareholdings (97 companies)
4 Jun 2007
Authorized signatory (ppa) (1)
4 Jun 2007
Authorized signatory (ppa) (1)
26 Mar 2007
Authorized signatory (ppa) (2)
5 Mar 2007
Capital: €151.5M · Company statute
19 Feb 2007 via DEGENEXUS OHG
General partner: DEGENEXUS OHG
9 Feb 2007
Patent: Stable Pharmaceutical Compositions Comprising an HMG-CoA Reductase Inhibitor
Year 2006 in Epobase
5 European patent filings: Liquid Presentations of Oxazaphosphorine-Containing Pharmaceutical Products …
Year 2006 in Dpmam
36 trademark filings (13 wordmarks, 1 word figurative mark): Cortisan, Cortix, Dermadex, Dignodolin, ELDISINE, EPO-cell, FENPATEC, FENTADERM, Fitamin, Flecainid AL, FlutiSal STADA, Fluticason S STADA …
11 Dec 2006
Authorized signatory (ppa) (1)
Year 2006 in Euipotm
4 trademark filings (2 wordmarks, 1 figurative mark, 1 word figurative mark): Bioloxan, CELL PHARM …
24 Oct 2006
No longer Member of the Executive Board (1)
23 Oct 2006
No longer Member of the Executive Board (1)
16 Oct 2006
Authorized signatory (ppa) (1)
25 Sept 2006
Member of the Executive Board (1)
18 Sept 2006
Company statute
4 Sept 2006
Authorized signatory (ppa) (4)
8 May 2006
No longer Member of the Executive Board (1)
15 Mar 2006
Patent: Verfahren zur Herstellung von Lichtschutzzubereitungen, umfassend organische UV-Filter in fester, feinverteilter Form
23 Feb 2006
No longer Authorized signatory (ppa) (2) · Member of the Executive Board (3) · Capital: €139.1M · Company statute
Year 2005 in Dpmam
42 trademark filings (14 wordmarks, 2 word figurative marks): BENAZEPLUS AL, Bonsolan, CLAIRE FISHER, CONSTITON, CONTRAZON, Cyprette AL, Cypronette AL, DIE ERSTE RUNDUM-VERSORGUNG VON MORGENS BIS …
Year 2005 in Dpmap
4 patent filings: Lichtschutzzubereitung mit Mikropigmenten …
7 Dec 2005
Patent: Ready to use Gemcitabin Solution Concentrates
2 Nov 2005
Patent: Use of antioxidants to make a pharmaceutical or cosmetic composition to protect the skin against damage caused by infrared radiation
19 Sept 2005
No longer Authorized signatory (ppa) (1)
8 Sept 2005
Registered ex officio: Entry dated 23.08.2005 corrected in: The Board of Directors has been appointed by resolution of …
23 Aug 2005
Date of the Annual General Meeting corrected ex officio: The Board of Directors has been approved by resolution of the …
17 Aug 2005
Date of the Annual General Meeting corrected ex officio: The Board of Directors has been approved by resolution of the …
4 Aug 2005
Authorized signatory (ppa) (1)
1 Aug 2005
Capital: €23.4M · Company statute · A the development, manufacture, distribution and trade of all kinds of products for the global healthcare market, in particular in the pharmaceutical, biotechnical …
21 Jul 2005
Authorized signatory (ppa) (1)
26 May 2005
Wordmark: “Immunisator“
20 Apr 2005
Patent: Cosmetic or Pharmaceutical Compositions for Topical Administration with Improved Stability
22 Mar 2005
No longer Member of the Executive Board (1)
22 Feb 2005
Authorized signatory (ppa) (1)
22 Feb 2005
Patent: Ready to use Gemcitabine Solutions and Concentrates
24 Aug 2004
Reg­is­tra­tion · ppa (6) · CxO (3) · Capital: €138.8M · Seat: Bad Vilbel · Legal form · Name: STADA Arzneimittel AG · Proxy policy · Company statute …
There are no publications matching your search.

Mentions

6 Oct 2025 in Psc
Companies House - Persons with Significant Control
in Ler
Direct parent (4 companies)
21 Feb 2025 in Hrcdd also 15/07/2014, 15/07/2014, 14/07/2014
Control, Control: Mobilat Produktions GmbH
20 Jan 2025 in Ler
Direct parent: Nidda German Topco GmbH
20 Jan 2025 in Ler
Ultimate parent: Nidda German Topco GmbH
11 Jan 2025 in Ler
Ultimate parent: EG N.V
5 Dec 2024 in Rne
Reg­is­tra­tion: 01/01/2020 · Segment clas­si­fi­ca­tion
28 Mar 2024 in Vr
Shareholding: Stada s.r.o., Člen Skupiny Stada
27 Mar 2024 in Vr
Shareholding: Walmark a.s
25 Mar 2024 in Vr
Shareholding: Stada Pharma CZ s.r.o
14 Sept 2021 in Hrdk also 03/12/2014
Natures Aid Deutschland GmbH: “Liste der Gesellschafter“
27 Apr 2020 in Ler
Ultimate parent: Stada UK Holdings Ltd
21 Jun 2017 in Hrdk
BEPHA Beteiligungsgesellschaft für Pharmawerte mbH: “Liste der Gesellschafter“
27 Aug 2015 in Bmjfbv
Shareholding: SCIOTEC Diagnostic Technologies GmbH
14 Jul 2009 in Hrdk
Mobilat Produktions GmbH: “Liste der Gesellschafter“
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "STADA Arzneimittel AG, Bad Vilbel, Germany" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.